Today: 17 November 2025
Subscribe
Browse Category

Corporate Actions News 27 October 2025 - 16 November 2025

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited heads into Monday’s open with investors still digesting a tough few months: a surprise guidance downgrade and delayed vaccines demerger at the late‑October AGM, followed by a steady drumbeat of daily buy‑back notices last week. Below is a clear, fact‑checked briefing on the latest numbers, announcements, and catalysts to watch before the bell. Where the stock last closed (Friday) The freshest company disclosures The big picture since August: restructure, guidance reset, and demerger timing Product & pipeline developments that still matter to valuation What to watch at Monday’s open 1) Follow‑through from Wall Street and sentiment reset. Friday’s
16 November 2025
 ·  ·  ·  · 
Light & Wonder (ASX:LNW) Completes Nasdaq Delisting, Fires Up A$10.8bn ASX Era With New Mega Buyback

Light & Wonder (ASX:LNW) Completes Nasdaq Delisting, Fires Up A$10.8bn ASX Era With New Mega Buyback

Light & Wonder, Inc. has officially left the Nasdaq and begun life as a sole listing on the Australian Securities Exchange (ASX), wrapping the move in a suite of shareholder‑friendly measures – including a huge new on‑market buyback, fresh governance documents, and an updated employee stock purchase plan effective today. IAG+2LNW Explore+2 At the close in Sydney, Light & Wonder’s CHESS Depositary Interests (CDIs) were trading around A$131.66, down about 2% on the day, valuing the cross‑platform gaming group at roughly A$10.8 billion (US$7.0 billion). GuruFocus+2Investing.com+2 Sole ASX listing now live after Nasdaq exit Light & Wonder’s transition from a
14 November 2025
 ·  ·  ·  · 
Moderna (MRNA) today — Nov. 12, 2025: Special shareholder vote on option exchange, fresh institutional filings, and live stock action

Moderna (MRNA) today — Nov. 12, 2025: Special shareholder vote on option exchange, fresh institutional filings, and live stock action

Published: Nov. 12, 2025 (updated intraday, UTC) Key points at a glance What’s happening today (Nov. 12, 2025) 1) Shareholders vote on employee option exchange Moderna is holding a virtual special meeting at 8:00 a.m. Eastern to seek approval for a one‑time exchange of “underwater” employee stock options (Executive Committee excluded). Per the definitive proxy, at 100% participation the plan would cancel options for ~5.65M shares and regrant options for ~2.21M, reducing option overhang by ~3.44M shares. The webcast URL and meeting logistics are outlined in the SEC filing. SEC+1 Why it matters: Lower option overhang can reduce prospective dilution
12 November 2025
 ·  ·  ·  ·  · 
Tata Capital’s ₹15,500-Crore IPO Rocks 2025 Markets – Should You Bet on India’s Biggest Listing?

Tata Motors Demerger: Commercial Vehicles arm to list on Nov 12 — symbol, timing, allotment ratio, and what to expect

Updated: November 11, 2025 Key takeaways What exactly is listing tomorrow? The CV business, earlier housed within Tata Motors, is debuting as a separately traded company on NSE and BSE on Wednesday, November 12. This is the final step of the restructuring that split the automaker into two listed entities: a passenger vehicles (PV) company (including EV and JLR) and a commercial vehicles company. mint+1 Under the approved scheme and subsequent corporate actions, the CV entity has been renamed “Tata Motors Limited,” while the erstwhile parent has changed its name to Tata Motors Passenger Vehicles Limited (TMPV) for the PV+EV+JLR
11 November 2025
 ·  ·  ·  · 
Barclays Shares Slump 5% in FTSE 100 Rout – Is It a Golden Buying Opportunity?

Barclays share price hits fresh 52‑week high on Nov. 11 as buyback and AT1 comeback fuel rally

Updated: November 11, 2025 Key points What happened today (Nov. 11, 2025) Barclays shares extended Monday’s momentum, pushing to a new 12‑month high near 426p and closing just shy of that mark. Real‑time pricing on Reuters showed intraday prints in the 425p–426p band, with previous close at 417.25p. Hargreaves Lansdown’s end‑of‑day snapshot recorded a +1.99% gain for the session. The FTSE 100 also finished firmer, providing a supportive backdrop for UK large‑cap financials. Reuters+1 A tangible near‑term catalyst was an RNS this morning: Barclays confirmed that on Nov. 10 it bought back 2,649,035 shares for cancellation (VWAP 415.2457p; high 417.95p;
11 November 2025
 ·  ·  ·  · 
AiRWA (YYAI) Soars on Crypto Pivot – Tiny Stock on a Wild Ride or Warning Sign?

YYAI Stock’s Wild Ride: $100M Crypto Pivot and 1-for-50 Reverse Split Shock Investors

YYAI’s Transformation: From Tennis Tech to Tokenized Finance YYAI’s recent saga is a dramatic pivot from its roots. Until this month, the Nasdaq-listed company was known as Connexa Sports Technologies, a small-cap firm specializing in sports training tech (like the Slinger Bag portable ball launcher and AI coaching analytics) ts2.tech. Facing stagnation and financial strain, Connexa’s management made a bold leap into the hottest buzzwords of 2025 – crypto and AI. On Oct. 6, 2025, they announced the company would rebrand as “AiRWA Inc.” and refocus entirely on blockchain-based financial services globenewswire.com globenewswire.com. The crown jewel of this plan is
27 October 2025
 ·  ·  ·  ·  · 
Go toTop